Elevance Health Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Elevance Health ha aumentado sus beneficios a una tasa media anual de 7.1%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 5.3% anual. Los ingresos han ido creciendo a una tasa media de 11.2% al año. La rentabilidad financiera de Elevance Health es de 14.6%, y sus márgenes netos son de 3.7%.

Información clave

7.1%

Tasa de crecimiento de los beneficios

9.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	11.2%
Rentabilidad financiera	14.6%
Margen neto	3.7%
Última actualización de beneficios	30 Sep 2024

Actualizaciones de resultados anteriores recientes

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Oct 29

Recent updates

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Oct 29

There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Aug 29

Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Aug 02

Elevance Health: Healthcare Services Segment Is Gaining Traction

Jul 31

Elevance Health: Buy A Dividend Growth Machine

Jul 18

Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)

Jun 28

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Jun 11

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

May 27

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

May 09

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Apr 25

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

Apr 23

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Apr 16

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Apr 11

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Apr 01

Elevance: A Healthy Dose Of Dividend Growth

Mar 21

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Mar 07

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Jan 19

Is Elevance Health (NYSE:ELV) A Risky Investment?

Jan 02

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Dec 18

A Look At Elevance's Margin Dynamics

Nov 23

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Nov 16

Elevance Health: A High Conviction Defensive Blue Chip Buy

Oct 19

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Oct 04

Elevance: Pave The Way For The Next UnitedHealth

Sep 21

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Sep 18

Here's The Price I Would Buy Elevance Health Stock

Sep 13

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Aug 18

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Aug 04

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Jul 24

Elevance Health: Beaten Down Share Price Offers Solid Potential

Jul 10

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Jul 05

Elevance Health: A Critical Update (Rating Downgrade)

Jun 05

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Jun 04

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

May 05

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Apr 04

Desglose de ingresos y gastos

Cómo gana y gasta dinero Elevance Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:ELV Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Sep 24	174,015	6,418	37,383
30 Jun 24	171,719	6,691	37,407
31 Mar 24	171,745	6,244	36,666
31 Dec 23	171,340	5,987	36,236
30 Sep 23	168,626	5,996	35,718
30 Jun 23	165,716	6,310	33,553
31 Mar 23	160,676	6,094	31,749
31 Dec 22	156,599	5,894	30,696
30 Sep 22	153,251	6,166	29,605
30 Jun 22	149,134	6,072	28,496
31 Mar 22	144,353	6,228	27,590
31 Dec 21	138,643	6,158	26,604
30 Sep 21	133,883	5,518	26,357
30 Jun 21	129,219	4,231	25,839
31 Mar 21	124,632	4,714	25,675
31 Dec 20	121,868	4,572	25,202
30 Sep 20	117,449	4,955	23,013
30 Jun 20	112,965	5,916	20,850
31 Mar 20	109,167	4,779	17,955
31 Dec 19	104,212	4,807	15,356
30 Sep 19	100,165	4,298	14,323
30 Jun 19	96,742	4,074	13,706
31 Mar 19	94,220	3,989	13,758
31 Dec 18	92,091	3,750	14,020
30 Sep 18	91,409	4,556	13,681
30 Jun 18	90,584	4,344	13,146
31 Mar 18	90,061	4,145	12,772
31 Dec 17	90,049	3,843	12,650
30 Sep 17	89,055	2,980	12,520
30 Jun 17	88,038	2,851	12,634
31 Mar 17	87,083	2,777	12,549
31 Dec 16	84,862	2,470	12,559
30 Sep 16	83,364	2,282	12,562
30 Jun 16	81,866	2,319	12,518
31 Mar 16	80,412	2,398	12,590
31 Dec 15	79,158	2,560	12,535
30 Sep 15	77,959	2,886	12,299
30 Jun 15	76,605	2,862	12,187
31 Mar 15	75,066	2,734	12,032
31 Dec 14	73,886	2,560	11,748
30 Sep 14	72,792	2,362	11,361
30 Jun 14	72,090	2,385	10,936
31 Mar 14	71,307	2,453	10,485
31 Dec 13	71,024	2,634	9,953

Ingresos de calidad: ELV tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (3.7%) de ELV son superiores a los del año pasado (3.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de ELV han crecido un 7.1% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de ELV en el último año (7%) está por debajo de su media de 5 años (7.1% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de ELV en el último año (7%) no superó al de la industria Healthcare 10.3%.

Elevance Health Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Elevance Health, Inc. to Report Q3, 2024 Results on Oct 17, 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations

Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024

First quarter 2024 earnings: EPS misses analyst expectations

Recent updates

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 22%, revenue upgraded

Price target decreased by 8.6% to US$552

Insider recently sold US$3.2m worth of stock

Third quarter dividend of US$1.63 announced

Elevance Health, Inc. (NYSE:ELV) agreed to acquire CareBridge Medical Group, P.C.

New minor risk - Dividend sustainability

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds

Elevance Health, Inc. Declares Dividend for the Fourth Quarter of 2024, Payable on December 20, 2024

Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Las Mercedes Medical Centers acquired Pasteur and Wellmax Medical Centers from Elevance Health, Inc. (NYSE:ELV).

Elevance Health, Inc. to Report Q3, 2024 Results on Oct 17, 2024

Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)

Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth

Upcoming dividend of US$1.63 per share

There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Clayton, Dubilier & Rice and Elevance Health Announces the Introduction of Mosaic Health, a National Care Delivery Platform

Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Elevance Health: Healthcare Services Segment Is Gaining Traction

President notifies of intention to sell stock

Second quarter dividend of US$1.63 announced

Second quarter 2024 earnings: EPS exceeds analyst expectations

Elevance Health: Buy A Dividend Growth Machine

Elevance Health, Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 25, 2024

Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)

Elevance Health, Inc. to Report Q2, 2024 Results on Jul 17, 2024

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Upcoming dividend of US$1.63 per share

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

Insider recently sold US$6.8m worth of stock

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

First quarter dividend of US$1.63 announced

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024

StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc.

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Elevance: A Healthy Dose Of Dividend Growth

Insider recently sold US$1.2m worth of stock

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Insider notifies of intention to sell stock

Upcoming dividend of US$1.63 per share

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health, Inc., Annual General Meeting, May 15, 2024

Fourth quarter dividend increased to US$1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024

Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Insider notifies of intention to sell stock

Upcoming dividend of US$1.48 per share at 1.2% yield

A Look At Elevance's Margin Dynamics

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Third quarter 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health: A High Conviction Defensive Blue Chip Buy